Andere talen Daewoong Co., Ltd.

Aandelen

A003090

KR7003090008

slotkoers Korea S.E. Andere beurzen 00:00:00 21-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
18.300 ^KRW	-1,82%		-5,03%	-11,38%

24/04	Koreaanse suikerimport daalt met 14% door toename diabetesgevallen	MT
08/03	Daewoong Co. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Korean Sugar Imports Plunge 14% as Diabetes Cases Surge	24/04
Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	08/03
Daewoong Pharmaceutical Secures Approval for Stem Cell Processing Facility in Indonesia	15/02
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.	05/02
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.	31/01
Daewoong Co., Ltd.'s Equity Buyback announced on July 27, 2023, has closed with 690,630 shares, representing 1.66% for KRW 9,997.24 million.	31/01
Zydus Unit, Daewoong Pharma to Co-Develop, Commercialize Leuprolide Acetate in US	11/12
Daewoong Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.	03/11
Hyphens Pharma Unit to Distribute Daewoong Pharmaceutical's Nabota Botox in Malaysia	30-08-23
Daewoong Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
Daewoong Pharmaceutical's Nabota Surpasses 600,000 Customers in the US	02-08-23
Daewoong Co., Ltd. announces an Equity Buyback for KRW 10,000 million worth of its shares.	27-07-23
Daewoong Co., Ltd. authorizes a Buyback Plan.	27-07-23
Avacta sees shares rise on new equity payment for South Korea venture	05-06-23
Daewoong Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	08-03-23
An Unknown buyer completed the acquisition of 66.2% stake in Palmpack Co., Ltd. from Daewoong Co., Ltd..	28-02-23
Sonoma Pharmaceuticals Signs Distribution Deal With Daewoong Pharmaceutical to Sell Skin Products in South Korea	31-01-23
Oncorus, Daewoong Pharmaceutical to Develop Lipid Nanoparticle Formulations for mRNA Drug Candidate; Shares Surge	04-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Daewoong Co., Ltd.

Aandelen

A003090

KR7003090008

Andere talen

Filters